$29.30
1.24% yesterday
NYSE, Sep 27, 10:10 pm CET
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Evolent Health Inc Class A Stock price

$29.30
-2.44 7.69% 1M
-3.43 10.48% 6M
-3.73 11.29% YTD
+2.50 9.33% 1Y
+2.57 9.61% 3Y
+22.05 304.14% 5Y
+10.44 55.36% 10Y
NYSE, Closing price Fri, Sep 27 2024
+0.36 1.24%
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Key metrics

Market capitalization $3.37b
Enterprise Value $4.06b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 26.93
EV/Sales (TTM) EV/Sales 1.73
P/S ratio (TTM) P/S ratio 1.43
P/B ratio (TTM) P/B ratio 3.15
Revenue growth (TTM) Revenue growth 44.25%
Revenue (TTM) Revenue $2.35b
EBIT (operating result TTM) EBIT $29.22m
Free Cash Flow (TTM) Free Cash Flow $150.93m
Cash position $121.30m
EPS (TTM) EPS $-0.94
P/E forward negative
P/S forward 1.31
EV/Sales forward 1.58
Short interest 14.30%
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Evolent Health Inc Class A forecast:

17x Buy
100%

Analyst Opinions

17 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
100%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,354 2,354
44% 44%
100%
- Direct Costs 2,039 2,039
53% 53%
87%
315 315
4% 4%
13%
- Selling and Administrative Expenses 161 161
12% 12%
7%
- Research and Development Expense - -
-
-
154 154
28% 28%
7%
- Depreciation and Amortization 125 125
10% 10%
5%
EBIT (Operating Income) EBIT 29 29
383% 383%
1%
Net Profit -74 -74
17% 17%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Positive
Seeking Alpha
about one month ago
Evolent Health is potentially being taken private at a bid of $3.8 billion, offering a 15% upside to the stock at $32 per share. The company's revenue growth rates are expected to decelerate, but potential bidding wars may drive up the stock price further. Evolent's current valuation at 21x forward free cash flow may undervalue the company, potentially leading to higher bids in the future.
Positive
Reuters
about one month ago
Evolent Health is in talks with private equity firms and other companies for a potential sale, in a process that kicked off after the healthcare services provider received inbound interest, people familiar with the matter said on Thursday.
Neutral
Seeking Alpha
about 2 months ago
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,700
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today